TransMedics Group, Inc. (TMDX) stock

TMDXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3029% below fair value

$91.38−0.62 (-0.67%)

Close on Nov 13, 2026Market cap $3.17BP/E 25.0Yield 0.00%

TransMedics statistics

106 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 23, 2027 (estimated, during market hours)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $3.17B; $498.53M
Enterprise Value: $2.73B; $433.11M
PE Ratio: 25.04; 29.52
PS Ratio: 4.35; 2.94
PB Ratio: 5.75; 3.24
P/TBV Ratio: 5.98; 4.81
P/FCF Ratio: 70.89; 26.31
P/OCF Ratio: 28.20; 21.97

Enterprise valuationIndustry

EV / Sales: 3.75; 2.60
EV / EBITDA: 21.52; 18.41
EV / EBIT: 31.59; 24.14
EV / FCF: 61.09; 27.51

Share statisticsIndustry

Shares Outstanding: 35M; 43M
Shares Change (YoY): 1.43%; 3.32%
Shares Change (QoQ): 0.27%; 0.20%
Float: 33M; 37M
Shares Held by Insiders: 3.91%; 10.5%
Shares Held by Institutions: 100.4%; 60.5%

Short sellingIndustry

Short Interest: 9M; –
Short Interest Change: 1.24%; -2.57%
Short % of Float: 26.6%; 5.11%
Short % of Shares Outstanding: 25.6%; 3.98%
Days to Cover: 10.22; 3.94

Stock price statisticsIndustry

52-Week High: $156.00; –
52-Week Low: $60.10; –
20-Day Moving Average: $76.30; –
50-Day Moving Average: $80.28; –
200-Day Moving Average: $91.63; –
Average True Range (14): $5.20; –
Price Change (1 Week): 3.56%; 0.99%
Price Change (1 Month): 19.4%; -3.52%
Price Change (3 Months): 3.43%; -7.86%
Price Change (6 Months): 44.6%; -1.12%
Price Change (YTD): -24.9%; -2.92%
Price Change (1 Year): -23.3%; -1.37%
Price Change (3 Years): 41.0%; 3.24%
Price Change (5 Years): 240.7%; -50.4%
Average Volume (10 Days): 2M; –
Average Volume (20 Days): 1M; –
Average Volume (90 Days): 917,422; –
Relative Volume: 0.92; 0.76
Relative Strength Index (14): 65.9; 46.7
Volatility (1 Year): 64.1%; 64.2%
Beta (5 Years): 1.34; 1.04

MarginsIndustry

Gross Margin: 58.6%; 55.9%
Operating Margin: 11.9%; -5.12%
Pretax Margin: 10.1%; -2.32%
Profit Margin: 19.9%; -9.29%
EBITDA Margin: 17.4%; -2.52%
FCF Margin: 6.14%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): 31.9%; -17.3%
Return on Assets (ROA): 11.7%; -12.3%
Return on Invested Capital (ROIC): 2622.0%; -2.83%
Return on Capital Employed (ROCE): 6.33%; -8.13%

Financial positionIndustry

Current Ratio: 4.53; 2.49
Quick Ratio: 3.98; 1.53
Debt / Equity: 0.10; 0.42
Debt / EBITDA: 0.43; 2.23
Debt / FCF: 1.23; 3.62
Net Debt / EBITDA: -3.45; 1.49
Interest Coverage: 3.46; -1.63

GrowthIndustry

Revenue Growth (YoY): 28.5%; 9.42%
Net Income Growth (YoY): 57.4%; 13.4%
EPS Growth (YoY): 47.8%; 15.1%
FCF Growth (YoY): -63.0%; 7.64%
Revenue Growth (3Y CAGR): 86.4%; 7.08%
Revenue Growth (5Y CAGR): 88.2%; 11.8%

EfficiencyIndustry

Asset Turnover: 0.59; 0.59
Inventory Turnover: 5.86; 2.20
Revenue Per Employee: $810.30K; $331.99K
Profits Per Employee: $160.86K; -$46.47K
Employee Count: 898; 193
WACC: 11.9%; 9.91%

Income statement (TTM)Industry

Revenue: $727.65M; $108.17M
Gross Profit: $426.43M; $62.29M
Operating Income: $86.45M; -$3.72M
Pretax Income: $73.62M; -$1.83M
Net Income: $144.45M; -$6.19M
EBITDA: $126.86M; -$1.98M
EPS (Diluted): $3.65; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $492.96M; $38.97M
Total Debt: $54.82M; $96.00M
Net Cash (Debt): $438.14M; $3.95M
Net Cash Per Share: $12.64; $0.26
Equity (Book Value): $550.71M; $63.80M
Book Value Per Share: $15.88; $3.26
Tangible Book Value: $529.88M; $11.61M
Working Capital: $539.60M; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: $112.36M; -$483.87K
Capital Expenditures: -$67.66M; -$3.94M
Free Cash Flow: $44.70M; -$238.00K
FCF Per Share: $1.29; -$0.00

Dividends and yieldsIndustry

Earnings Yield: 4.56%; -4.76%
FCF Yield: 1.41%; 0.28%
Dividend Yield: 0.00%; 0.79%
Shareholder Yield: 0.00%; 1.12%
Dividend Per Share: $0.00; $0.72
Years of Dividend Growth: 0; 0

Taxes and interestIndustry

Interest Expense: $25.02M; $5.40M
Income Tax: -$70.83M; $1.55M
Effective Tax Rate: -96.2%; 18.0%

Scores and fair valueIndustry

Graham Number: $36.12; $38.11
Graham Upside: -60.5%; -56.1%
Altman Z-Score: 2.84; 2.47
Piotroski F-Score: 6; 5
Beneish M-Score: -1.44; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	TMDX	S&P 500	Difference	TMDX per year	S&P 500 per year
1 month	+15.5%	-3.0%	+18.5 pts
3 months	+1.9%	-2.8%	+4.7 pts
Year to date	-24.9%	+11.5%	−36.4 pts
1 year	-20.9%	+13.5%	−34.4 pts
3 years	+53.2%	+77.7%	−24.5 pts	+15.3%	+21.1%
5 years	+240.7%	+72.6%	+168.1 pts	+27.8%	+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

9M TMDX shares were sold short on Oct 30, 2026, up 1.2% from the previous report, or 26.64% of the shares available to trade. At recent volumes it would take 10.2 days to buy them back. Over the last 20 sessions, 51.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	8,877,506	+1.2%	869,058	10.2
Oct 15, 2026	8,769,040	+2.5%	886,863	9.9
Sep 30, 2026	8,551,869	+7.2%	654,562	13.1
Sep 15, 2026	7,977,125	-1.3%	747,124	10.7
Aug 31, 2026	8,079,087	+2.1%	632,347	12.8
Aug 14, 2026	7,910,244	+3.1%	1,179,701	6.7
Jul 31, 2026	7,672,830	-0.6%	807,866	9.5
Jul 15, 2026	7,715,332	-1.9%	809,077	9.5
Jun 30, 2026	7,865,697	+2.4%	1,301,889	6.0
Jun 15, 2026	7,680,998	+4.4%	1,065,864	7.2
May 29, 2026	7,356,977	-10.0%	1,381,681	5.3
May 15, 2026	8,178,039	-1.7%	2,419,508	3.4